| タイトル |
Rationale and design of the VISION study: a randomized, open-label study to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive esophagitis
|
| 著者 |
Uemura Naomi
Haruma Ken
Yao Takashi
Kushima Ryoji
Kanoo Tatsuhiro
|
| 収録物名 |
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY
|
| 巻 | 11 |
| 開始ページ | 51 |
| 終了ページ | 56 |
| 収録物識別子 |
ISSN 1178-7023
|
| 主題 |
erosive esophagitis; gastric mucosa; lansoprazole; long-term safety; vonoprazan; K+ competitive channel inhibitor; neoplasia
|
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
DOVE MEDICAL PRESS LTD
|
| 発行日 | 2018 |
| アクセス権 | メタデータのみ |
| 関連情報 |
[DOI] 10.2147/CEG.S144149
[PMID] 29416369
|
| 備考 | This study is funded by Takeda Pharmaceutical Co., Ltd. Takeda Pharmaceutical Co., Ltd has been involved in the planning and design of this study, and has contributed to the development and approval of the present manuscript. The final decision to submit the paper, however, lay directly with the authors. The authors acknowledge all patients who are participating in this study and their families, as well as all staff at all investigational sites. The authors thank Kouji Miyata (Takeda Pharmaceutical Co., Ltd Japan) for critical review of the manuscript and suggestions for improvement. The authors also acknowledge Rachel Moir of FireKite (an Ashfield company, part of UDG Healthcare plc), who provided medical writing assistance during the development of this manuscript, which was funded by Takeda Pharmaceutical Co., Ltd and complied with Good Publication Practice 3 ethical guidelines. |
